# Merck & Co. Inc (NYSE: MRK), Rahway, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/merck-co-inc/a46a094a-b27d-49bf-bde5-42441f92c622

> Inspection records and compliance data for Merck & Co. Inc in Rahway, New Jersey. 16 FDA inspections on record (1 OAI), 2 Form 483s, last inspected August 14, 2026. Publicly traded as NYSE: MRK.

---

## Details

- Name: Merck & Co. Inc
- FEI Number: 2211017
- Address Line 1: 126 E Lincoln Ave
- City: Rahway
- State: New Jersey
- Zip Code: 07065
- Country Name: United States
- Address: 126 E Lincoln Ave, Rahway, New Jersey 07065, United States
- Country: United States

## Stock

- Stock ticker: MRK
- Exchange: NYSE
- Share price: $146.99
- Market cap: $362.4B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1329118 - Merck & Co. Inc - 2026-08-14 — source: FDA, date: August 14, 2026
- FDA Inspection 1305632 - Merck & Co. Inc - 2026-03-13 — source: FDA, date: March 13, 2026
- [FDA Inspection 1283890 - Merck & Co. Inc - 2025-12-18](https://www.keypedia.com/records/fda_inspections/merck-co-inc/3db085e5-9756-4923-a078-ed1c7815373b) — source: FDA, date: December 18, 2025
- FDA Inspection 1262774 - Merck & Co. Inc - 2025-05-16 — source: FDA, date: May 16, 2025
- FDA Inspection 1262774 - Merck & Co. Inc - 2025-05-16 — classification: No Action Indicated (NAI), source: FDA, date: May 16, 2025
- FDA Inspection 1264192 - Merck & Co. Inc - 2025-03-27 — source: FDA, date: March 27, 2025
- FDA Inspection 1264192 - Merck & Co. Inc - 2025-03-27 — classification: No Action Indicated (NAI), source: FDA, date: March 27, 2025
- FDA Inspection 1158317 - Merck & Co. Inc - 2021-11-18 — classification: No Action Indicated (NAI), source: FDA, date: November 18, 2021
- FDA Inspection 1156008 - Merck & Co. Inc - 2021-10-27 — classification: No Action Indicated (NAI), source: FDA, date: October 27, 2021
- [EIR - Merck & Co. Inc - 2019-09-06](https://www.keypedia.com/records/eir/merck-co-inc/c7e8cc93-30f7-4f77-8b72-51df9de21d0b) — source: FDA, date: September 6, 2019
- [FDA Inspection 1101464 - Merck & Co. Inc - 2019-09-06](https://www.keypedia.com/records/fda_inspections/merck-co-inc/64a70c11-e5e9-499f-bbb8-71fe4817fc59) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2019
- [483 - Merck & Co. Inc - 2016-08-26](https://www.keypedia.com/records/483/merck-co-inc/c734e6e3-310b-4d49-a3c1-36825b6ea22b) — source: FDA, date: August 26, 2016
- [483 - Merck & Co. Inc - 2015-11-19](https://www.keypedia.com/records/483/merck-co-inc/0aff043d-e9b8-420c-b9e3-04ea44273bb9) — source: FDA, date: November 19, 2015

## Related Companies

- [Boehringer Ingelheim Pharmaceuticals, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-pharmaceuticals-inc/437c28a1-054f-4c22-9dba-fd40af58a7be)
- [Patheon Biologics (NJ) LLC](https://www.keypedia.com/companies/patheon-biologics-nj-llc/5d009aee-a952-4eee-a975-1b2bd0559e04)
- [Ranbaxy Inc.](https://www.keypedia.com/companies/ranbaxy-inc/83cb62ce-f991-473a-a24b-f5951066c481)
- [Clario Inc](https://www.keypedia.com/companies/clario-inc/8f2d1f68-f3d8-4389-8100-efca010d9051)
- [Bristol Myers Squibb](https://www.keypedia.com/companies/bristol-myers-squibb/6be6b425-4587-4e43-9934-b3cda7b6457c)
- [Amneal Pharmaceuticals, Llc](https://www.keypedia.com/companies/amneal-pharmaceuticals-llc/1727fcb2-2120-4a7c-a93b-a52aa106268f)
- [Ascend Laboratories, LLC](https://www.keypedia.com/companies/ascend-laboratories-llc/13da97c0-bcd0-4d01-9c02-8a46b089cfc5)
- [Sandoz Incorporated](https://www.keypedia.com/companies/sandoz-incorporated/6aa8ae0e-b0f0-49a7-a584-c6e6796c6481)
- [Dario D. Altamirano, DO](https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2)
- [Daniel J. DeAngelo, MD](https://www.keypedia.com/companies/daniel-j-deangelo-md/9a6d0cc8-13b8-4412-b0b4-933a9ef1352c)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/christina-burkhart/ab17df57-2a72-4262-920c-c63cb8f52114)
- [Cynthia Kleppinger](https://www.keypedia.com/people/cynthia-kleppinger/8badb3bc-141f-4094-a02b-b572fdb68fbf)
- [investigator](https://www.keypedia.com/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)
- [Shirley S. Wen](https://www.keypedia.com/people/shirley-s-wen/eafbc8e5-a0ac-443a-adaf-ced505f77842)
- [company_representative](https://www.keypedia.com/people/mary-ellen-monahan/04c746f9-fe9e-4b56-a74f-5789aa8fecda)
- [company_representative](https://www.keypedia.com/people/steven-talerico/0dd0fbb3-70a9-455e-ba90-de8ffe7e4c14)